SEARCH RESULTS

11 RESULTS

Michal Schwartz on Cancer Treatment Takes Aim at Tauopathy

COMMENT With regard to Latta-Mahieu et al., 2018, I am confident that the three groups that published this paper would have been able to repeat the positive effect of anti-PD-1 antibody on plaque burden, if they had calibrated the antibody and the treatment ...

Michal Schwartz on ALS-TDI Scours Transcriptome, Targets CD40L

COMMENT This article elegantly shows the strength of transcriptome analysis for the rapid discovery of a new drug. In this study, the authors identified the therapeutic potential of modulating CD40L in ALS using an animal model. Through transcriptome analysis, ...

Current Filters

  • TYPE: Comment x
  • Commentator: Schwartz, Michal x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE